NHTC Plunges to Q3 Loss Amidst Sales Decline, Cash Flow Woes

TL;DR

**NHTC is bleeding cash and losing money, making it a risky bet for any investor looking for stability or growth.**

AI Summary

NATURAL HEALTH TRENDS CORP. (NHTC) reported a significant decline in financial performance for the three and nine months ended September 30, 2025. Net sales decreased to $9.477 million for the three months ended September 30, 2025, down from $10.691 million in the prior year, representing a 11.4% decrease. For the nine months, net sales fell to $30.027 million from $32.117 million, a 6.5% reduction. The company posted a net loss of $0.431 million for the third quarter of 2025, a stark contrast to the net income of $0.035 million in the same period of 2024. The nine-month period also saw a net loss of $0.294 million, compared to a net income of $0.396 million in 2024. Operating cash flows remained negative, with a net cash outflow of $5.038 million for the nine months ended September 30, 2025, worsening from a $3.455 million outflow in the prior year. Total assets decreased from $55.359 million at December 31, 2024, to $42.251 million at September 30, 2025, primarily due to a reduction in marketable securities from $30.407 million to $17.672 million. The company continues to face risks related to its substantial reliance on Hong Kong and China operations, negative operating cash flows, and intense competition in the direct-selling industry.

Why It Matters

NHTC's continued decline in net sales and a shift from net income to net loss signals significant operational challenges, particularly for investors concerned about profitability and growth. The persistent negative operating cash flows, worsening from $3.455 million to $5.038 million year-over-year, indicate a fundamental issue in generating cash from core business activities, which could impact the company's ability to fund future operations or dividends. Employees and customers might face uncertainty given the company's struggles in a highly competitive direct-selling market, especially with its heavy reliance on the volatile Greater China region. This performance suggests NHTC is losing ground against competitors like Herbalife and Nu Skin, which could lead to further market share erosion.

Risk Assessment

Risk Level: high — NHTC exhibits a high risk level due to its consistent negative operating cash flows, reaching -$5.038 million for the nine months ended September 30, 2025, and a shift from net income to a net loss of -$0.431 million in Q3 2025. Furthermore, the company's significant reliance on its Hong Kong and China operations, which account for a substantial portion of its business, exposes it to considerable geopolitical and economic risks, as explicitly stated in the forward-looking statements.

Analyst Insight

Investors should consider divesting NHTC shares or avoiding new positions given the deteriorating financial performance, including declining sales and persistent net losses. The worsening negative operating cash flow and high exposure to geopolitical risks in China and Hong Kong suggest a challenging outlook for the company's stability and future growth.

Financial Highlights

debt To Equity

N/A

revenue

$30.027M

operating Margin

N/A

total Assets

$42.251M

total Debt

N/A

net Income

$(0.294)M

eps

$(0.03)

gross Margin

73.76%

cash Position

$14.336M

revenue Growth

-6.5%

Revenue Breakdown

Key Numbers

• $9.477M — Net Sales (Q3 2025) (Decreased from $10.691M in Q3 2024, an 11.4% decline.)
• $(0.431)M — Net Income (Loss) (Q3 2025) (Shifted from a net income of $0.035M in Q3 2024 to a net loss.)
• $(0.294)M — Net Income (Loss) (9 Months 2025) (Shifted from a net income of $0.396M in 9 Months 2024 to a net loss.)
• $(5.038)M — Net Cash Used in Operating Activities (9 Months 2025) (Worsened from $(3.455)M in 9 Months 2024, indicating increasing cash burn.)
• $14.336M — Cash and Cash Equivalents (Sept 30, 2025) (Slight increase from $13.533M at Dec 31, 2024, despite negative operating cash flow, likely due to marketable securities maturities.)
• $17.672M — Marketable Securities (Sept 30, 2025) (Significant decrease from $30.407M at Dec 31, 2024, impacting total assets.)
• $42.251M — Total Assets (Sept 30, 2025) (Decreased from $55.359M at Dec 31, 2024, reflecting asset reduction.)
• $26.148M — Total Stockholders' Equity (Sept 30, 2025) (Decreased from $32.872M at Dec 31, 2024, due to net losses and dividends.)
• 11,513,075 — Shares Outstanding (Oct 31, 2025) (Stable share count, but per-share metrics are impacted by losses.)
• $0.20 — Dividends Declared Per Share (Quarterly) (Consistent dividend payout despite net losses, contributing to equity reduction.)

Key Players & Entities

• NATURAL HEALTH TRENDS CORP. (company) — registrant
• NHTC (company) — trading symbol
• Hong Kong (company) — significant operational market
• China (company) — significant operational market
• $9.477 million (dollar_amount) — net sales for Q3 2025
• $10.691 million (dollar_amount) — net sales for Q3 2024
• $0.431 million (dollar_amount) — net loss for Q3 2025
• $0.035 million (dollar_amount) — net income for Q3 2024
• $5.038 million (dollar_amount) — net cash used in operating activities for nine months ended Sept 30, 2025
• $3.455 million (dollar_amount) — net cash used in operating activities for nine months ended Sept 30, 2024

FAQ

Risk Factors

• Negative Operating Cash Flow [high — financial]: The company reported a net cash outflow of $5.038 million for the nine months ended September 30, 2025, an increase from $3.455 million in the prior year. This sustained negative operating cash flow indicates a significant cash burn and raises concerns about the company's ability to fund its operations without external financing.
• Reliance on Hong Kong and China [high — market]: The company's substantial reliance on its operations in Hong Kong and China presents a significant risk. Any adverse political, economic, or regulatory changes in these regions could disproportionately impact the company's overall financial performance.
• Intense Competition [medium — market]: The direct-selling industry is characterized by intense competition. NHTC faces challenges from numerous players offering similar personal care and wellness products, which could pressure pricing and market share.
• Declining Sales and Profitability [high — financial]: Net sales decreased by 11.4% to $9.477 million in Q3 2025 and by 6.5% to $30.027 million for the nine months ended September 30, 2025. The company also shifted from net income to a net loss of $0.431 million in Q3 2025 and $0.294 million for the nine months, indicating a deteriorating financial performance.
• Asset Reduction [medium — financial]: Total assets decreased from $55.359 million at December 31, 2024, to $42.251 million at September 30, 2025. This reduction was primarily driven by a significant decrease in marketable securities from $30.407 million to $17.672 million, suggesting a potential liquidation of assets.
• Dividend Payout Amidst Losses [medium — financial]: The company declared a quarterly dividend of $0.20 per share despite incurring net losses. This dividend payout, totaling $2.4397 million for the nine months based on shares outstanding, contributes to the reduction in stockholders' equity from $32.872 million to $26.148 million.

Industry Context

Natural Health Trends Corp. operates in the international direct-selling and e-commerce sector, focusing on personal care and wellness products. This industry is highly competitive, with numerous companies vying for market share through multi-level marketing and online sales channels. Trends include a growing consumer interest in health and wellness products, but also increasing scrutiny on direct-selling business models and regulatory compliance.

Regulatory Implications

The company's operations in various international markets, particularly China, expose it to diverse regulatory environments. Compliance with local laws regarding product safety, marketing practices, and direct selling is crucial. Any missteps could lead to fines, operational disruptions, or reputational damage.

What Investors Should Do

1. Monitor cash burn and liquidity
2. Assess geographic concentration risk
3. Evaluate the sustainability of dividends
4. Analyze the impact of asset liquidation

Key Dates

• 2025-09-30: End of Third Quarter 2025 — Reporting period for the 10-Q, showing declining sales, net losses, and negative operating cash flow.
• 2025-12-31: End of Fiscal Year 2024 — Balance sheet comparison point, showing higher total assets ($55.359M) and marketable securities ($30.407M) compared to Q3 2025.
• 2025-02-21: Filing of 2024 Form 10-K — Provides the basis for comparison for the current interim financial statements.

Glossary

Marketable securities

Short-term, highly liquid investments that can be readily converted into cash. (A significant decrease in marketable securities from $30.407 million to $17.672 million impacted total assets and cash flow dynamics.)

Accumulated deficit

The cumulative net losses of a company that have not been offset by net income. (The accumulated deficit increased to $(33.547) million from $(26.344) million, reflecting the company's recent net losses.)

Operating lease right-of-use assets

An asset representing the right to use an underlying leased asset for the lease term. (These assets decreased from $2.498 million to $2.031 million, indicating a reduction in leased assets.)

Deferred revenue

Revenue that has been received by the company but not yet earned. (Deferred revenue decreased from $6.428 million to $6.011 million, suggesting a reduction in future revenue obligations.)

eWallets

Digital wallets used for storing payment information and conducting transactions. (Amounts held in eWallets decreased from $3.286 million to $2.977 million.)

Year-Over-Year Comparison

Compared to the prior year, Natural Health Trends Corp. has experienced a significant downturn. Net sales for the nine months ended September 30, 2025, declined by 6.5% to $30.027 million, and the company shifted from a net income of $0.396 million to a net loss of $0.294 million. Operating cash flow worsened considerably, with an outflow of $5.038 million compared to $3.455 million in the prior year. Total assets have also decreased by $13.108 million, largely due to a reduction in marketable securities.

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share NHTC The NASDAQ Stock Mar

Filing Documents

• nhtc20250930_10q.htm (10-Q) — 1435KB
• ex_846316.htm (EX-31.1) — 10KB
• ex_846317.htm (EX-31.2) — 10KB
• ex_846318.htm (EX-32.1) — 10KB
• 0001437749-25-033153.txt ( ) — 6747KB
• nhtc-20250930.xsd (EX-101.SCH) — 50KB
• nhtc-20250930_cal.xml (EX-101.CAL) — 42KB
• nhtc-20250930_def.xml (EX-101.DEF) — 320KB
• nhtc-20250930_lab.xml (EX-101.LAB) — 297KB
• nhtc-20250930_pre.xml (EX-101.PRE) — 354KB
• nhtc20250930_10q_htm.xml (XML) — 1334KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 1 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 22 Item 4.

Controls and Procedures

Controls and Procedures 22

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 23 Item 1A.

Risk Factors

Risk Factors 23 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23 Item 3. Defaults Upon Senior Securities 23 Item 4. Mine Safety Disclosures 23 Item 5. Other Information 23 Item 6. Exhibits 24

Signatures

Signatures 25 Table of Contents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q, in particular "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations," includes "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). When used in this report, the words or phrases "will likely result," "expect," "intend," "will continue," "anticipate," "estimate," "project," "believe" and similar expressions are intended to identify "forward-looking statements" within the meaning of the Exchange Act. These statements represent our expectations or beliefs concerning, among other things, future revenue, earnings, growth strategies, new products and initiatives, dividend policies, future operations and operating results, and future business and market opportunities. Forward-looking statements in this report speak only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. We caution and advise readers that these statements are based on certain assumptions that may not be realized and involve risks and uncertainties that could cause actual results to differ materially from the expectations and beliefs contained herein. For a summary of certain risks related to our business, see "Part I, Item 1A. Risk Factors" in our most recent Annual Report on Form 10-K, and "Part II, Item 1A. Risk Factors" in this Quarterly Report on Form 10-Q, which include the following: Changes in government trade and economic policies, including the imposition of tariffs and other restrictive trade policies, and ongoing political and economic disputes between the United States and other jurisdictions, particularly China, may have a negative effect on global economic conditions and our business, financial results and financial condition; Because our Hong Kong o

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

Item 1. FINANCIAL STATEMENTS NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In Thousands, Except Share Data) September 30, 2025 December 31, 2024 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 14,336 $ 13,533 Marketable securities 17,672 30,407 Inventories 2,154 3,272 Other current assets 3,726 3,771 Total current assets 37,888 50,983 Property and equipment, net 170 190 Operating lease right-of-use assets 2,031 2,498 Restricted cash 35 34 Deferred tax asset 246 382 Other assets 1,881 1,272 Total assets $ 42,251 $ 55,359 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,011 $ 895 Income taxes payable 7 4,908 Accrued commissions 1,751 2,021 Other accrued expenses 1,484 1,425 Deferred revenue 6,011 6,428 Amounts held in eWallets 2,977 3,286 Operating lease liabilities 991 1,127 Other current liabilities 523 709 Total current liabilities 14,755 20,799 Deferred tax liability 173 174 Operating lease liabilities 1,175 1,514 Total liabilities 16,103 22,487 Commitments and contingencies (Note 7) Stockholders' equity: Preferred stock, $ 0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding — — Common stock, $ 0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at September 30, 2025 and December 31, 2024 13 13 Additional paid-in capital 85,004 84,901 Accumulated deficit ( 33,547 ) ( 26,344 ) Accumulated other comprehensive loss ( 925 ) ( 1,301 ) Treasury stock, at cost; 1,466,339 shares at September 30, 2025 and December 31, 2024 ( 24,397 ) ( 24,397 ) Total stockholders' equity 26,148 32,872 Total liabilities and stockholders' equity $ 42,251 $ 55,359 See accompanying notes to consolidated financial statements. 1 Table of Contents NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In Thousands, Except Per Share Data) Three Months E

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Natural Health Trends Corp., a Delaware corporation (whether or not including its subsidiaries, the "Company"), is an international direct-selling and e-commerce company. Subsidiaries controlled by the Company sell personal care, wellness, and "quality of life" products under the "NHT Global" brand. The Company's wholly-owned subsidiaries have an active physical presence in the following markets: the Americas, which consists of the United States, Canada, Cayman Islands, Mexico, Peru and Colombia; Greater China, which consists of Hong Kong, Taiwan and China; Southeast Asia, which consists of Malaysia and Singapore ; South Korea; Japan; India; and Europe. The Company also operates in Russia and Kazakhstan through an engagement with a local service provider. Basis of Presentation The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10 -Q and Rule 10 - 01 of Regulation S- X. As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial information for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and

View Full Filing

View this 10-Q filing on SEC EDGAR